Insider Trading: Achillion Pharmaceuticals Inc (ACHN.O)

ACHN.O on Nasdaq

8.13USD
19 Jun 2013
Price Change (% chg)

$0.12 (+1.50%)
Prev Close
$8.01
Open
$8.03
Day's High
$8.25
Day's Low
$7.86
Volume
744,381
Avg. Vol
1,026,248
52-wk High
$11.36
52-wk Low
$5.42

Search Stocks
VITULLO NICOLE Options Exercised: 0
Trade Date: Wednesday, 30 May 2012 Price: 0.00
Title: Director and Beneficial Owner Shares Held: 6,950,563
Type Traded: Indirect Net Change in Shares This Filing: -1,106,566
» More Insider Trading

Institutional Holders

% Shares Owned: 0.00%
# of Holders: 181
Total Shares Held: 100,719,022
3 Mo. Net Change: 16,643,116
# New Positions: 30
# Closed Positions: 17
# Increased Positions: 104
# Reduced Positions: 54
# Net Buyers: 50

Officers & Directors

Name Age Since Current Position

David Scheer

 60 2010 Chairman of the Board

Milind Deshpande

 55 2013 President, Chief Executive Officer, Director

Mary Kay Fenton

 48 2010 Chief Financial Officer, Senior Vice President

Gautam Shah

 56 2012 Executive Vice President, Chief Compliance Officer

David Apelian

 47 2013 Executive Vice President, Chief Medical Officer

Joseph Truitt

 48 2012 Senior Vice President, Chief Commercial Officer

Michael Kishbauch

 63 2013 Director

Jason Fisherman

 54 2000 Independent Director

Gary Frashier

 74 2008 Independent Director

Kurt Graves

 44 2012 Independent Director

Dennis Liotta

 2008 Independent Director

Robert Van Nostrand

 55 2007 Independent Director

Nicole Vitullo

 53 2010 Independent Director
Search Stocks